Combination of Empagliflozin and Metformin Therapy: A Consideration of Its Place in Type 2 Diabetes Therapy

Clinical Medicine Insights: Endocrinology and Diabetes - United Kingdom
doi 10.1177/1179551418786258
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Empagliflozin and Metformin Combination Therapy in Type 2 Diabetes Mellitus

International Journal of Basic and Clinical Pharmacology
2015English

Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2015English

Pioglitazone and Metformin Fixed-Dose Combination in Type 2 Diabetes Mellitus: An Evidence-Based Review of Its Place in Therapy

Core Evidence
MedicineReviewsReferencesPharmacology
2007English

Effect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes Mellitus

JAMA - Journal of the American Medical Association
Medicine
2000English

Combination Therapy With DPP-4 Inhibitors and Pioglitazone in Type 2 Diabetes: Theoretical Consideration and Therapeutic Potential

Vascular Health and Risk Management
2008English

Pharmacoeconomic Analysis of the Use of a Fixed Dose Combination of Metformin and Glibenclamide in the Therapy of Diabetes Mellitus Type 2

Pharmacoeconomics: theory and practice
2016English

A Clinical Study on Adverse Drug Reactions of Combination Therapy of Dapagliflozin and Metformin in the Treatment of Type 2 Diabetes Mellitus

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2017English

Clinical Considerations for Use of Initial Combination Therapy in Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2016English

Rationale and Options for Combination Therapy in the Treatment of Type 2 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy